Hiv Vaccine Market Report

China Hiv Vaccine Industry Market Research Report 2023-2029

  • POSTDATE：Aug 22, 2023
  • PAGES：194
  • REPORT CODE：GMM1750696
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • An HIV vaccine may have the purpose of protecting individuals who do not have HIV from being infected with the virus (a preventative vaccine), or treating an HIV-infected person (a therapeutic vaccine). There are two approaches to an HIV vaccine: an active vaccination approach in which a vaccine aims to induce an immune response against HIV; and a passive vaccination approach in which preformed antibodies against HIV are administered.

    This report elaborates on the current development of the Hiv Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis

    • Bionor Pharmaceuticals

    • GeneCure

    • Oncolys Biopharma

    • Immune Response BioPharma

    • Argo Therapeutics

    • AlphaVax

    • TVAX Biomedical

    • Profectus Biosciences

    • Glaxo Smithkline

    • GenVec

    • PaxVax

    • Inovio Pharmaceuticals

    • Crucell Pharmaceutical

    • Antigen Express

    • GeoVax Labs

    • Celldex Therapeutics

    By Type:

    • Preventive Vaccine

    • Therapeutic Vaccine

    By Application:

    • Early Aged

    • Infants

    • Post Aged

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Hiv Vaccine Market Overview 2018-2029

    • 1.1 China Hiv Vaccine Industry Development Overview

    • 1.2 China Hiv Vaccine Industry Development History

    • 1.3 China Hiv Vaccine Industry Market Size (2018-2029)

    • 1.4 China Hiv Vaccine Market Analysis by Type from Production Side

      • 1.4.1 China Hiv Vaccine Production Volume, Production Value and Growth Rate of Preventive Vaccine (2018-2029)

      • 1.4.2 China Hiv Vaccine Production Volume, Production Value and Growth Rate of Therapeutic Vaccine (2018-2029)

    • 1.5 China Hiv Vaccine Market Analysis by Application from Consumption End

      • 1.5.1 China Hiv Vaccine Sales Volume, Sales Value and Growth Rate of Early Aged (2018-2029)

      • 1.5.2 China Hiv Vaccine Sales Volume, Sales Value and Growth Rate of Infants (2018-2029)

      • 1.5.3 China Hiv Vaccine Sales Volume, Sales Value and Growth Rate of Post Aged (2018-2029)

    • 1.6 China Hiv Vaccine Market Analysis by Region

      • 1.6.1 North China Hiv Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Hiv Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Hiv Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Hiv Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Hiv Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Hiv Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Hiv Vaccine Market Size and Growth Rate from 2018-2029

    Chapter 2 China Hiv Vaccine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Hiv Vaccine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Hiv Vaccine Market Status and Competition Analysis in 2023

      • 2.2.3 China Hiv Vaccine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Hiv Vaccine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Hiv Vaccine Industry Development

    Chapter 3 Hiv VaccineIndustry Chain Analysis

    • 3.1 Hiv Vaccine Industry Chain

    • 3.2 Hiv Vaccine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Hiv Vaccine Market

    • 3.3 Hiv Vaccine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Hiv Vaccine Market

    Chapter 4 China Hiv Vaccine Market, by Type

    • 4.1 China Hiv Vaccine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Hiv Vaccine Total Production Volume and Growth Rate from Production Side

    • 4.5 China Hiv Vaccine Production Volume and Growth Rate, by Type

      • 4.5.1 China Hiv Vaccine Production Volume and Growth Rate of Preventive Vaccine

      • 4.5.2 China Hiv Vaccine Production Volume and Growth Rate of Therapeutic Vaccine

    Chapter 5 China Hiv Vaccine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Hiv Vaccine Total Market Size and Growth Rate from Consumption End

    • 5.5 China Hiv Vaccine Market Size and Growth Rate, by Application

      • 5.5.1 China Hiv Vaccine Market Size and Growth Rate of Early Aged

      • 5.5.2 China Hiv Vaccine Market Size and Growth Rate of Infants

      • 5.5.3 China Hiv Vaccine Market Size and Growth Rate of Post Aged

    Chapter 6 China Hiv Vaccine Market, by Region

    • 6.1 China Hiv Vaccine Production Volume and Production Value, by Region

    • 6.2 China Hiv Vaccine Sales Volume and Sales Value, by Region

    Chapter 7 North China Hiv Vaccine Market Analysis

    • 7.1 North China Hiv Vaccine Market, by Type

    • 7.2 North China Hiv Vaccine Market, by Application

    Chapter 8 Central China Hiv Vaccine Market Analysis

    • 8.1 Central China Hiv Vaccine Market, by Type

    • 8.2 Central China Hiv Vaccine Market, by Application

    Chapter 9 South China Hiv Vaccine Market Analysis

    • 9.1 South China Hiv Vaccine Market, by Type

    • 9.2 South China Hiv Vaccine Market, by Application

    Chapter 10 East China Hiv Vaccine Market Analysis

    • 10.1 East China Hiv Vaccine Market, by Type

    • 10.2 East China Hiv Vaccine Market, by Application

    Chapter 11 Northeast China Hiv Vaccine Market Analysis

    • 11.1 Northeast China Hiv Vaccine Market, by Type

    • 11.2 Northeast China Hiv Vaccine Market, by Application

    Chapter 12 Southwest China Hiv Vaccine Market Analysis

    • 12.1 Southwest China Hiv Vaccine Market, by Type

    • 12.2 Southwest China Hiv Vaccine Market, by Application

    Chapter 13 Northwest China Hiv Vaccine Market Analysis

    • 13.1 Northwest China Hiv Vaccine Market, by Type

    • 13.2 Northwest China Hiv Vaccine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis

        • 14.1.1 Novartis Company Profile

        • 14.1.2 Novartis Hiv Vaccine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bionor Pharmaceuticals

        • 14.2.1 Bionor Pharmaceuticals Company Profile

        • 14.2.2 Bionor Pharmaceuticals Hiv Vaccine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 GeneCure

        • 14.3.1 GeneCure Company Profile

        • 14.3.2 GeneCure Hiv Vaccine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Oncolys Biopharma

        • 14.4.1 Oncolys Biopharma Company Profile

        • 14.4.2 Oncolys Biopharma Hiv Vaccine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Immune Response BioPharma

        • 14.5.1 Immune Response BioPharma Company Profile

        • 14.5.2 Immune Response BioPharma Hiv Vaccine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Argo Therapeutics

        • 14.6.1 Argo Therapeutics Company Profile

        • 14.6.2 Argo Therapeutics Hiv Vaccine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AlphaVax

        • 14.7.1 AlphaVax Company Profile

        • 14.7.2 AlphaVax Hiv Vaccine Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 TVAX Biomedical

        • 14.8.1 TVAX Biomedical Company Profile

        • 14.8.2 TVAX Biomedical Hiv Vaccine Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Profectus Biosciences

        • 14.9.1 Profectus Biosciences Company Profile

        • 14.9.2 Profectus Biosciences Hiv Vaccine Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Glaxo Smithkline

        • 14.10.1 Glaxo Smithkline Company Profile

        • 14.10.2 Glaxo Smithkline Hiv Vaccine Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 GenVec

        • 14.11.1 GenVec Company Profile

        • 14.11.2 GenVec Hiv Vaccine Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 PaxVax

        • 14.12.1 PaxVax Company Profile

        • 14.12.2 PaxVax Hiv Vaccine Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Inovio Pharmaceuticals

        • 14.13.1 Inovio Pharmaceuticals Company Profile

        • 14.13.2 Inovio Pharmaceuticals Hiv Vaccine Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Crucell Pharmaceutical

        • 14.14.1 Crucell Pharmaceutical Company Profile

        • 14.14.2 Crucell Pharmaceutical Hiv Vaccine Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Antigen Express

        • 14.15.1 Antigen Express Company Profile

        • 14.15.2 Antigen Express Hiv Vaccine Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 GeoVax Labs

        • 14.16.1 GeoVax Labs Company Profile

        • 14.16.2 GeoVax Labs Hiv Vaccine Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Celldex Therapeutics

        • 14.17.1 Celldex Therapeutics Company Profile

        • 14.17.2 Celldex Therapeutics Hiv Vaccine Market Performance

        • 14.17.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Hiv Vaccine Industry Research Conclusions

    • 15.2 Hiv Vaccine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Hiv Vaccine Industry Market Size (2018-2029)

    • Figure China Hiv Vaccine Production Volume, Production Value and Growth Rate of Preventive Vaccine (2018-2029)

    • Figure China Hiv Vaccine Production Volume, Production Value and Growth Rate of Therapeutic Vaccine (2018-2029)

    • Figure China Hiv Vaccine Sales Volume, Sales Value and Growth Rate of Early Aged (2018-2029)

    • Figure China Hiv Vaccine Sales Volume, Sales Value and Growth Rate of Infants (2018-2029)

    • Figure China Hiv Vaccine Sales Volume, Sales Value and Growth Rate of Post Aged (2018-2029)

    • Figure North China Hiv Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Central China Hiv Vaccine Market Size and Growth Rate from 2018-2029

    • Figure South China Hiv Vaccine Market Size and Growth Rate from 2018-2029

    • Figure East China Hiv Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Hiv Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Hiv Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Hiv Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Hiv Vaccine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Hiv Vaccine Market Share by Type in 2018

    • Figure China Hiv Vaccine Market Share by Type in 2023

    • Figure China Hiv Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Hiv Vaccine Production Volume and Growth Rate of Preventive Vaccine (2018-2023)

    • Figure China Hiv Vaccine Production Volume and Growth Rate of Therapeutic Vaccine (2018-2023)

    • Figure China Hiv Vaccine Market Share by Application in 2018

    • Figure China Hiv Vaccine Market Share by Application in 2023

    • Figure China Hiv Vaccine Total Market Size and Growth Rate from Consumption End

    • Figure China Hiv Vaccine Market Size and Growth Rate of Early Aged (2018-2023)

    • Figure China Hiv Vaccine Market Size and Growth Rate of Infants (2018-2023)

    • Figure China Hiv Vaccine Market Size and Growth Rate of Post Aged (2018-2023)

    • Table China Hiv Vaccine Production Volume by Region (2018-2023)

    • Table China Hiv Vaccine Production Volume Share by Region (2018-2023)

    • Figure China Hiv Vaccine Production Volume Share by Region (2018-2023)

    • Table China Hiv Vaccine Production Value by Region (2018-2023)

    • Table China Hiv Vaccine Production Value Share by Region (2018-2023)

    • Figure China Hiv Vaccine Production Value Share by Region (2018-2023)

    • Table China Hiv Vaccine Sales Volume by Region (2018-2023)

    • Table China Hiv Vaccine Sales Volume Share by Region (2018-2023)

    • Figure China Hiv Vaccine Sales Volume Share by Region (2018-2023)

    • Table China Hiv Vaccine Sales Value by Region (2018-2023)

    • Table China Hiv Vaccine Sales Value Share by Region (2018-2023)

    • Figure China Hiv Vaccine Sales Value Share by Region (2018-2023)

    • Table North China Hiv Vaccine Production Volume by Type (2018-2023)

    • Table North China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Figure North China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Table North China Hiv Vaccine Sales Volume by Application (2018-2023)

    • Table North China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Figure North China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Table Central China Hiv Vaccine Production Volume by Type (2018-2023)

    • Table Central China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Figure Central China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Table Central China Hiv Vaccine Sales Volume by Application (2018-2023)

    • Table Central China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Central China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Table South China Hiv Vaccine Production Volume by Type (2018-2023)

    • Table South China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Figure South China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Table South China Hiv Vaccine Sales Volume by Application (2018-2023)

    • Table South China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Figure South China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Table East China Hiv Vaccine Production Volume by Type (2018-2023)

    • Table East China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Figure East China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Table East China Hiv Vaccine Sales Volume by Application (2018-2023)

    • Table East China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Figure East China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northeast China Hiv Vaccine Production Volume by Type (2018-2023)

    • Table Northeast China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northeast China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Table Northeast China Hiv Vaccine Sales Volume by Application (2018-2023)

    • Table Northeast China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Table Southwest China Hiv Vaccine Production Volume by Type (2018-2023)

    • Table Southwest China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Figure Southwest China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Table Southwest China Hiv Vaccine Sales Volume by Application (2018-2023)

    • Table Southwest China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northwest China Hiv Vaccine Production Volume by Type (2018-2023)

    • Table Northwest China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northwest China Hiv Vaccine Production Volume Share by Type (2018-2023)

    • Table Northwest China Hiv Vaccine Sales Volume by Application (2018-2023)

    • Table Northwest China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Hiv Vaccine Sales Volume Share by Application (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Bionor Pharmaceuticals Company Profile

    • Table Bionor Pharmaceuticals Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table GeneCure Company Profile

    • Table GeneCure Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Oncolys Biopharma Company Profile

    • Table Oncolys Biopharma Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Immune Response BioPharma Company Profile

    • Table Immune Response BioPharma Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Argo Therapeutics Company Profile

    • Table Argo Therapeutics Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table AlphaVax Company Profile

    • Table AlphaVax Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table TVAX Biomedical Company Profile

    • Table TVAX Biomedical Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Profectus Biosciences Company Profile

    • Table Profectus Biosciences Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Glaxo Smithkline Company Profile

    • Table Glaxo Smithkline Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table GenVec Company Profile

    • Table GenVec Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table PaxVax Company Profile

    • Table PaxVax Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Inovio Pharmaceuticals Company Profile

    • Table Inovio Pharmaceuticals Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Crucell Pharmaceutical Company Profile

    • Table Crucell Pharmaceutical Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Antigen Express Company Profile

    • Table Antigen Express Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table GeoVax Labs Company Profile

    • Table GeoVax Labs Hiv Vaccine Revenue, Price and Gross (2018-2023)

    • Table Celldex Therapeutics Company Profile

    • Table Celldex Therapeutics Hiv Vaccine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US